Your browser doesn't support javascript.
loading
The interaction of Epstein-Barr virus encoded transcription factor EBNA2 with multiple sclerosis risk loci is dependent on the risk genotype.
Keane, Jeremy Thomas; Afrasiabi, Ali; Schibeci, Stephen Donald; Swaminathan, Sanjay; Parnell, Grant Peter; Booth, David Richmond.
Afiliación
  • Keane JT; Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • Afrasiabi A; Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia; BioMedical Machine Learning Lab, The Graduate School of Biomedical Engineering, UNSW Sydney, Sydney, NSW 2052, Australia.
  • Schibeci SD; Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia.
  • Swaminathan S; Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia; Department of Medicine, Western Sydney University, Sydney, NSW 2560, Australia.
  • Parnell GP; Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia. Electronic address: grant.parnell@sydney.edu.au.
  • Booth DR; Centre for Immunology and Allergy Research, Westmead Institute for Medical Research, University of Sydney, Sydney, Australia. Electronic address: david.booth@sydney.edu.au.
EBioMedicine ; 71: 103572, 2021 Sep.
Article en En | MEDLINE | ID: mdl-34488019

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Antígenos Nucleares del Virus de Epstein-Barr / Esclerosis Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: EBioMedicine Año: 2021 Tipo del documento: Article País de afiliación: Australia

Texto completo: 1 Colección: 01-internacional Banco de datos: MEDLINE Asunto principal: Factores de Transcripción / Antígenos Nucleares del Virus de Epstein-Barr / Esclerosis Múltiple Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Humans Idioma: En Revista: EBioMedicine Año: 2021 Tipo del documento: Article País de afiliación: Australia